Safety of Early Discharge after High-dose Ara C Consolidation
Omyma Elemam1, Syed Z Zaidi2, Abdulaziz Al-Humaidi2, Basim AlBeirouti3, Ali Al-Shanqeeti4
1 Oncology Center, King Abdullah Medical City, Makkah, Kingdom of Saudi Arabia, Medical Oncology, Oncology Center, Mansoura University, Mansoura, Egypt 2 Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia P.O Box 59046, Riyadh 11525, Saudi Arabia 3 Oncology unit, King Abulaziz university Hospital, Jeddah, Saudi Arabia P.O Box 80215, Jeddah 21589, Saudi Arabia 4 National Center for Biotechnology, King Abdulaziz City for Science and Technology, King Abdullah Road, Building 17, Second Floor, Riyadh, Saudi Arabia
Correspondence Address:
Ali Al-Shanqeeti National Center for Biotechnology, King Abdulaziz City for Science and Technology, King Abdullah Road, Building 17, Second Floor, Riyadh Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |

|